Markets:

Overview

News

Currencies

International

Treasuries

Hemostemix Inc (OP:HMTXF)

0.0496 +0.0058 (+13.24%)

Streaming Delayed Price Updated: 11:13 AM EDT, Aug 19, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Hemostemix Inc

Hemostemix Leadership Attending Abundance360 Summit

March 09, 2026

Calgary, Alberta--(Newsfile Corp. - March 9, 2026) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) today announced that Thomas...

Via Newsfile

Topics Artificial Intelligence

Hemostemix Appoints Renowned Vascular Surgeon and Principal Investigator, Dr. York Hsiang, as Business Consultant to Advance First Nations-Led Healthcare Partnerships

February 03, 2026

Calgary, Alberta--(Newsfile Corp. - February 3, 2026) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous stem...

Via Newsfile

Hemostemix Receives FDA Support for Its Basket Protocol Approach

January 16, 2026

Calgary, Alberta--(Newsfile Corp. - January 16, 2026) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous stem...

Via Newsfile

Hemostemix Closes $480,000 Private Placement at $0.12 per Share

December 31, 2025

Calgary, Alberta--(Newsfile Corp. - December 31, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (the "Company" or "Hemostemix"),...

Via Newsfile

Hemostemix Appoints Dr. David B. Alper, to Lead Multidisciplinary Physician Education in the Use of ACP-01

December 23, 2025

Calgary, Alberta--(Newsfile Corp. - December 23, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company"),...

Via Newsfile

Hemostemix CEO Introduces Conformal Consciousness Hypothesis A = E/(hv)

December 11, 2025

Calgary, Alberta--(Newsfile Corp. - December 11, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) the leading autologous (patient's...

Via Newsfile

Hemostemix Grants Stock Options

December 11, 2025

Calgary, Alberta--(Newsfile Corp. - December 11, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company")...

Via Newsfile

Hemostemix Inc. Announces FDA Pre-IND Meeting and NBPP of $960,000

December 10, 2025

Calgary, Alberta--(Newsfile Corp. - December 10, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company"),...

Via Newsfile

Life Sciences Virtual Investor Forum: Presentations Now Available for Online Viewing

September 18, 2025

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com

From Virtual Investor Conferences

Via GlobeNewswire

Life Science Virtual Investor Forum Agenda Announced for September 18th

September 16, 2025

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com

From Virtual Investor Conferences

Via GlobeNewswire

Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing

March 14, 2025

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com

From Virtual Investor Conferences

Via GlobeNewswire

Life Sciences Investor Forum Agenda Announced for March 13th

March 12, 2025

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com

From Virtual Investor Conferences

Via GlobeNewswire

Hemostemix Announces the Appointment of Dr. Ernst von Schwarz, MD, PhD, FESC, FACC, FSCAI to Its Scientific Advisory Board

September 27, 2022

Calgary, Alberta--(Newsfile Corp. - September 27, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VFO) ("Hemostemix" or the "Company")...

Via Newsfile

Hemostemix Announces the Appointment of Dr. Terry Hébert, PhD, to Its Scientific Advisory Board

September 20, 2022

Calgary, Alberta--(Newsfile Corp. - September 20, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VFO) ("Hemostemix" or the "Company")...

Via Newsfile

Hemostemix Announces the Appointment of Dr. Nadia Giannetti, MD, to its Scientific Advisory Board

September 16, 2022

Calgary, Alberta--(Newsfile Corp. - September 16, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VFO) ("Hemostemix" or the "Company") is...

Via Newsfile

Hemostemix Announces the Appointment of Dr. Johannes Grillari to its Scientific Advisory Board

September 15, 2022

Calgary, Alberta--(Newsfile Corp. - September 15, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) ("Hemostemix" or the "Company") is pleased to...

Via Newsfile

Topics Intellectual Property

Hemostemix Announces the Appointment of Dr. Renzo Cecere, MD, FRCSC to Its Scientific Advisory Board

September 14, 2022

Calgary, Alberta--(Newsfile Corp. - September 14, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) ("Hemostemix" or the "Company") is pleased...

Via Newsfile

Hemostemix Announces Its Presentation to the Emerging Growth Conference

September 14, 2022

Calgary, Alberta--(Newsfile Corp. - September 14, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company")...

Via Newsfile

Topics Economy Intellectual Property

Hemostemix Announces the Appointment of Thomas Abraham, CA as President, PreCerv Inc.

September 13, 2022

Calgary, Alberta--(Newsfile Corp. - September 13, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) ("Hemostemix" or the "Company") is pleased...

Via Newsfile

Hemostemix Announces Closing of $2,750,000

April 26, 2022

Hemostemix Announces Closing of $2,750,000 - IssueWire

Via IssueWire

Topics Intellectual Property

Hemostemix Inc. Announces Intellectual Property Due Diligence and Data Audit Completed

April 13, 2022

Hemostemix Inc. Announces Intellectual Property Due Diligence and Data Audit Completed - IssueWire

Via IssueWire

Topics Intellectual Property Lawsuit

Your Fountain of Youth Trademarked by Hemostemix Inc.

March 03, 2022

Your Fountain of Youth Trademarked by Hemostemix Inc. - IssueWire

Via IssueWire

Topics Intellectual Property

Hemostemix Announces Closing of UNIT Private Placement

March 03, 2022

Hemostemix Announces Closing of UNIT Private Placement - IssueWire

Via IssueWire

Epigenetics, Psychedelics and Stem Cell Therapy are Topics of the Life Sciences Virtual Investor Conference Launching This Thursday ↗

December 14, 2021

Photo by Chris Montgomery on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial...

Via Benzinga

Hemostemix Announces the First of a Series of 2021 Video Interviews with ACP-01 Recipients: What the Successful Compassionate Treatment of Ischemic Cardiomyopathy Looks Like After 13 Years

September 14, 2021

Calgary, Alberta--(Newsfile Corp. - September 14, 2021) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) ("Hemostemix" or the "Company") is pleased...

Via Newsfile

Topics Economy Intellectual Property

Hemostemix Provides Update of Phase II Clinical Trial, 9th Circuit Court Decision Including Cost Award and its Annual General Meeting Results

July 06, 2021

Calgary, Alberta--(Newsfile Corp. - July 6, 2021) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) ‎‎(FSE: 2VFO) ("Hemostemix" or the "Company")...

Via Newsfile

Topics Economy Intellectual Property

Peter Lacey Increases His Investment in Hemostemix Inc.

June 21, 2021

Calgary, Alberta--(Newsfile Corp. - June 21, 2021) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) ‎‎(FSE: 2VFO) ("Hemostemix" or the "Company")...

Via Newsfile

Topics Intellectual Property

Hemostemix Announces the Closing of a $2,500,000 Convertible Debenture

June 11, 2021

Calgary, Alberta--(Newsfile Corp. - June 11, 2021) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) ‎‎(FSE: 2VFO) ("Hemostemix" or the "Company") is pleased...

Via Newsfile

Topics Economy Intellectual Property

Hemostemix Announces Completion of Phase II Clinical Trial Subject Follow Up and HMTXF Up-list

April 23, 2021

Calgary, Alberta--(Newsfile Corp. - April 23, 2021) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) ‎‎(FSE: 2VFO.F) ("Hemostemix" or the "Company")...

Via Newsfile

Topics Economy Intellectual Property

Hemostemix Announces It Is Trading on the Frankfurt Stock Exchange and It Has Retained HE Capital Markets Ltd.

April 08, 2021

Calgary, Alberta--(Newsfile Corp. - April 8, 2021) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VF0.F) ("Hemostemix" or the...

Via Newsfile

Topics Economy Intellectual Property

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Hemostemix Inc (OP:HMTXF)

All News about Hemostemix Inc

Starting at /week.